Aoyama T - Search Results

1

[Mechanism of the onset and development of nonalcoholic steatohepatitis and PPAR].

Tanaka N, Aoyama T. Tanaka N, et al. Among authors: aoyama t. Nihon Shokakibyo Gakkai Zasshi. 2002 Jun;99(6):563-9. Nihon Shokakibyo Gakkai Zasshi. 2002. PMID: 12099000 Japanese. No abstract available.

2

[Possible mechanisms of hepatitis C virus-related hepatocarcinogenesis].

Tanaka N, Aoyama T. Tanaka N, et al. Among authors: aoyama t. Nihon Rinsho. 2004 Nov;62(11):2137-44. Nihon Rinsho. 2004. PMID: 15552900 Review. Japanese.

3

[PPAR and NASH].

Tanaka N, Aoyama T. Tanaka N, et al. Among authors: aoyama t. Nihon Rinsho. 2006 Jun;64(6):1089-94. Nihon Rinsho. 2006. PMID: 16768114 Review. Japanese.

4

Identification of functions of peroxisome proliferator-activated receptor alpha in proximal tubules.

Kamijo Y, Hora K, Tanaka N, Usuda N, Kiyosawa K, Nakajima T, Gonzalez FJ, Aoyama T. Kamijo Y, et al. Among authors: aoyama t. J Am Soc Nephrol. 2002 Jul;13(7):1691-702. doi: 10.1097/01.asn.0000018403.61042.56. J Am Soc Nephrol. 2002. PMID: 12089364

5

In vivo stabilization of nuclear retinoid X receptor alpha in the presence of peroxisome proliferator-activated receptor alpha.

Tanaka N, Hora K, Makishima H, Kamijo Y, Kiyosawa K, Gonzalez FJ, Aoyama T. Tanaka N, et al. Among authors: aoyama t. FEBS Lett. 2003 May 22;543(1-3):120-4. doi: 10.1016/s0014-5793(03)00423-x. FEBS Lett. 2003. PMID: 12753917 Free article.

6

Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage.

Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, Tanaka E, Kiyosawa K, Fukushima Y, Peters JM, Gonzalez FJ, Aoyama T. Nakajima T, et al. Among authors: aoyama t. Hepatology. 2004 Oct;40(4):972-80. doi: 10.1002/hep.20399. Hepatology. 2004. PMID: 15382117

7

Suppression of expression of muscle-associated proteins by PPARalpha in brown adipose tissue.

Tong Y, Hara A, Komatsu M, Tanaka N, Kamijo Y, Gonzalez FJ, Aoyama T. Tong Y, et al. Among authors: aoyama t. Biochem Biophys Res Commun. 2005 Oct 14;336(1):76-83. doi: 10.1016/j.bbrc.2005.08.041. Biochem Biophys Res Commun. 2005. PMID: 16125138

8

Haploinsufficiency in the PPARalpha and LDL receptor genes leads to gender- and age-specific obesity and hyperinsulinemia.

Sugiyama E, Tanaka N, Nakajima T, Kamijo Y, Yokoyama S, Li Y, Gonzalez FJ, Aoyama T. Sugiyama E, et al. Among authors: aoyama t. Biochem Biophys Res Commun. 2006 Nov 17;350(2):370-6. doi: 10.1016/j.bbrc.2006.09.048. Epub 2006 Sep 20. Biochem Biophys Res Commun. 2006. PMID: 17011521

9

PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.

Tanaka N, Moriya K, Kiyosawa K, Koike K, Gonzalez FJ, Aoyama T. Tanaka N, et al. Among authors: aoyama t. J Clin Invest. 2008 Feb;118(2):683-94. doi: 10.1172/JCI33594. J Clin Invest. 2008. PMID: 18188449 Free PMC article.

10

Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis.

Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Tanaka N, et al. Among authors: aoyama t. J Clin Gastroenterol. 2008 Apr;42(4):413-8. doi: 10.1097/MCG.0b013e31815591aa. J Clin Gastroenterol. 2008. PMID: 18277895 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,348 results

Search Page

Filters